Savara (SVRA) Total Current Liabilities (2010 - 2026)

Savara (SVRA) reported Total Current Liabilities of $15.5 million for Q1 2026, up 30.6% year-over-year from $11.9 million in Q1 2025, and down 23.81% quarter-over-quarter from $20.4 million in Q4 2025.

Savara (SVRA) Total Current Liabilities (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Total Current Liabilities data on file, last reported at $15.5 million in Q1 2026.

  • Total Current Liabilities for Q1 2026 came in at $15.5 million, up 30.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.5 million (up 30.6% YoY), and the FY2025 annual result was $20.4 million, up 38.52% from the prior year.
  • Total Current Liabilities eased to $15.5 million in Q1 2026 per SVRA's latest filing, from $20.4 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $20.4 million in Q4 2025 and troughed at $3.7 million in Q2 2022.
  • A 5-year average of $11.1 million and a median of $11.3 million in 2024 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Total Current Liabilities jumped 126.49% in 2022, then sank 69.85% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $5.9 million in 2022, then jumped by 80.62% to $10.6 million in 2023, then jumped by 38.94% to $14.7 million in 2024, then soared by 38.52% to $20.4 million in 2025, then fell by 23.81% to $15.5 million in 2026.
  • Business Quant data shows SVRA's Total Current Liabilities at $15.5 million in Q1 2026, $20.4 million in Q4 2025, and $16.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 1.70 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 16.35 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 636.40 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 13.42 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 3.88 Bn
9 Abivax 94.37 Bn 94.37 Bn - 72.86 Mn
10 Savara 1.28 Bn 1.28 Bn - 15.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.54 Mn
Dec 31, 2025 20.40 Mn
Sep 30, 2025 16.76 Mn
Jun 30, 2025 13.63 Mn
Mar 31, 2025 11.90 Mn
Dec 31, 2024 14.72 Mn
Sep 30, 2024 12.79 Mn
Jun 30, 2024 11.29 Mn
Mar 31, 2024 9.81 Mn
Dec 31, 2023 10.60 Mn
Sep 30, 2023 8.96 Mn
Jun 30, 2023 5.89 Mn
Mar 31, 2023 4.92 Mn
Dec 31, 2022 5.87 Mn
Sep 30, 2022 5.16 Mn
Jun 30, 2022 3.71 Mn
Mar 31, 2022 16.32 Mn
Dec 31, 2021 14.66 Mn
Sep 30, 2021 10.66 Mn
Jun 30, 2021 5.64 Mn